ACAD
40.22
+0.39
+0.98%
AEMD
8.85
+0.1
+1.14%
APRI
1.5
-0.06
-3.85%
ARNA
4.2
-0.04
-0.94%
ATEC
1.35
-0.09
-6.25%
CNAT
5.32
-0.22
-3.97%
CRXM
0.5
+0.01
+2.04%
CYTX
0.681
-0.022
-3.0609%
DXCM
68.25
-0.92
-1.33%
GNMK
9.03
-0.08
-0.88%
HALO
17.25
+0.4
+2.37%
ILMN
203.12
+1.15
+0.57%
INNV
0.15
0.00
+0.84%
INO
8.26
+0.05
+0.61%
ISCO
0.05
0.00
-5.66%
ISIS
67.17
-0.39
-0.58%
LGND
89.23
+2.45
+2.82%
LPTN
0.297
-0.048
-13.938%
MBVX
2.38
-0.03
-1.24%
MEIP
1.91
-0.1
-4.98%
MNOV
4
-0.02
-0.50%
MRTX
25.84
-1.44
-5.28%
MSTX
0.505
+0.005
+1.000%
NBIX
41.98
-1.02
-2.37%
NUVA
48.23
-0.09
-0.19%
ONCS
0.233
0.00
0.00%
ONVO
4.68
0.00
0.00%
OREX
5
-0.03
-0.60%
OTIC
31.05
-0.6
-1.90%
QDEL
22.73
-0.25
-1.09%
RCPT
160.11
-3.1
-1.90%
RGLS
12.75
-0.31
-2.37%
RMD
57.32
+0.07
+0.12%
SCIE
0.015
-0.005
-23.6181%
SPHS
0.859
+0.082
+10.539%
SRNE
13.21
-0.43
-3.15%
TROV
10.29
-0.37
-3.47%
VICL
0.89
-0.04
-4.30%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
+0.01
+0.72%
ACAD
40.22
+0.39
+0.98%
AEMD
8.85
+0.1
+1.14%
APRI
1.5
-0.06
-3.85%
ARNA
4.2
-0.04
-0.94%
ATEC
1.35
-0.09
-6.25%
CNAT
5.32
-0.22
-3.97%
CRXM
0.5
+0.01
+2.04%
CYTX
0.681
-0.022
-3.0609%
DXCM
68.25
-0.92
-1.33%
GNMK
9.03
-0.08
-0.88%
HALO
17.25
+0.4
+2.37%
ILMN
203.12
+1.15
+0.57%
INNV
0.15
0.00
+0.84%
INO
8.26
+0.05
+0.61%
ISCO
0.05
0.00
-5.66%
ISIS
67.17
-0.39
-0.58%
LGND
89.23
+2.45
+2.82%
LPTN
0.297
-0.048
-13.938%
MBVX
2.38
-0.03
-1.24%
MEIP
1.91
-0.1
-4.98%
MNOV
4
-0.02
-0.50%
MRTX
25.84
-1.44
-5.28%
MSTX
0.505
+0.005
+1.000%
NBIX
41.98
-1.02
-2.37%
NUVA
48.23
-0.09
-0.19%
ONCS
0.233
0.00
0.00%
ONVO
4.68
0.00
0.00%
OREX
5
-0.03
-0.60%
OTIC
31.05
-0.6
-1.90%
QDEL
22.73
-0.25
-1.09%
RCPT
160.11
-3.1
-1.90%
RGLS
12.75
-0.31
-2.37%
RMD
57.32
+0.07
+0.12%
SCIE
0.015
-0.005
-23.6181%
SPHS
0.859
+0.082
+10.539%
SRNE
13.21
-0.43
-3.15%
TROV
10.29
-0.37
-3.47%
VICL
0.89
-0.04
-4.30%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
+0.01
+0.72%
Home » Archive by Category

Xconomy

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place

April 6, 2015 – 12:00 am

I’ve reached the stage of my career where I’ve been invited to give “career retrospective talks” to grad students and post-docs at academic institutions. It’s been an interesting and enjoyable…

[[Click headline to continue reading.]]

Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place

April 6, 2015 – 12:00 am

I’ve reached the stage of my career where I’ve been invited to give “career retrospective talks” to grad students and post-docs at academic institutions. It’s been an interesting and enjoyable…

[[Click headline to continue reading.]]